Non-invasive CTS Device Clinical Trial

Completed · Not applicable · Has a placebo group

Conditions studied: Carpal Tunnel Syndrome

In brief

Sham-controlled, multi-center and remote patient-centered randomized controlled clinical trial to investigate the efficacy of a novel non-invasive, unobtrusive study device in reducing symptoms of carpal tunnel syndrome (CTS). Daily wear of the study device is expected to significantly reduce symptom severity (evaluated by the Boston Carpal Tunnel Questionnaire) in mild to severe CTS-diagnosed patients. Subjects are randomized into the active device group or sham group for 8 weeks, then followed for 12 weeks post-treatment.

Key facts

Study ID

NCT03498287

Run by

Pressure Profile Systems, Inc.

People needed

88

Starts

2018-10-10

Expected to finish

2020-04-21

Last updated by the study team

2020-07-14

Who can join

Age: 21 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Clinically diagnosed with mild to severe carpal tunnel syndrome (CTS)
• CTS diagnosis confirmed by a nerve conduction study (NCS) performed within the past 24 months OR at enrollment/baseline visit
• CTS severity determined via AANEM criteria 13
• Bilateral CTS accepted (worse wrist via NCS and/or BCTQ is designated as the study wrist)
• BCTQ SSS > 2
• Reliable access to and ability to use Internet, Wi-Fi, or mobile data through computers, mobile devices, laptops, and/or tablets
• Willing to abstain from any other treatment or therapies for CTS throughout the study
• Ability to read and write English, or has a reliable person to assist with reading and writing English

You may not qualify if…

• Other upper extremity neuropathies (e.g., epicondylitis, radial nerve neuropathies, ulnar nerve neuropathies)
• Double crush syndrome
• Cervical stenosis
• Brachial plexopathy
• Wrist fractures or cysts
• Prior wrist surgeries, especially carpal tunnel release surgery
• Injection of corticosteroid/cortisone into the wrist or hand within the past 6 months
• Thyroid disease
• Rheumatoid arthritis
• Diabetes
• Systemic diseases
• Connective tissue diseases
• Fibromyalgia or chronic pain syndrome
• Diabetic neuropathy
• BMI > 40
• Participation in other research studies or clinical trials currently or within the past 2 weeks.
• To assess eligibility, visit: carpaltunneltrial.com

Where it is running

• Mission Pain & Spine — Mission Viejo, California, United States
• South Bay Medical Center — Torrance, California, United States
• Cleveland Clinic (Lerner Research Institute) — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.